key: cord-0431397-4qsixw38 authors: Patterson, B. J.; Dinkele, R.; Gessner, S.; Morrow, C.; Kamariza, M.; Bertozzi, C. R.; Kamholz, A.; Bryden, W.; Call, C.; Warner, D. F.; Wood, R. title: Sensitivity Optimisation of Tuberculosis Bioaerosol Sampling date: 2020-05-08 journal: nan DOI: 10.1101/2020.05.03.20089425 sha: 4e0ca67fa59dc24d16f8bb0136af90d152608d8a doc_id: 431397 cord_uid: 4qsixw38 Introduction: Detection of Mycobacterium tuberculosis (Mtb) in patient-derived bioaerosol is a potential tool to measure source case infectiousness. However, current bioaerosol sampling approaches have reported low detection yields in sputum-positive TB cases. To increase the utility of bioaerosol sampling, we present advances in bioaerosol collection and Mtb identification that improve detection yields. Methods: A previously described Respiratory Aerosol Sampling Chamber (RASC) protocol, or 'RASC-1', was modified to incorporate liquid collection of bioaerosol using a high-flow wet-walled cyclone (RASC-2). Individuals with GeneXpert-positive pulmonary TB were sampled pre-treatment over 60-minutes. Putative Mtb bacilli were detected in collected fluid by fluorescence microscopy utilising DMN-Trehalose. Exhaled air and bioaerosol volumes were estimated using continuous CO2 monitoring and airborne particle counting, respectively. Mtb capture was calculated per exhaled air volume sampled and bioaerosol volume for RASC-1 (n=35) and for RASC-2 (n=21). Empty chamber samples were collected between patients as controls. Results: The optimised RASC-2 protocol sampled a median of 258.4L (IQR: 226.9-273.6) of exhaled air per patient compared with 27.5L (IQR: 23.6-30.3) for RASC-1 (p<0.0001). Bioaerosol volume collection was estimated at 2.3nL (IQR: 1.1-3.6) for RASC-2 compared with 0.08nL (IQR: 0.05-0.10) for RASC-1 (p<0.0001). The detection yield of viable Mtb improved from 43% (median 2 CFU, range: 1-14) to 95% (median 20.5 DMN-Trehalose positive bacilli, range: 2-155). These improvements represent a lowering of the limit of detection in the RASC-2 platform to 0.9 Mtb bacilli per 100L of exhaled air from 3.3 Mtb bacilli per 100L (RASC-1). Conclusion: This study demonstrates that technical improvements in particle collection together with sensitive detection enable rapid quantitation of viable Mtb in bioaerosols of sputum positive TB cases. Increased sampling sensitivity may allow future TB transmission studies to be extended to sputum-negative and subclinical individuals, and suggests the potential utility of bioaerosol measurement for rapid intervention in other airborne infectious diseases. Introduction Detection of Mycobacterium tuberculosis (Mtb) in patient-derived bioaerosol is a potential tool to 48 measure source case infectiousness. However, current bioaerosol sampling approaches have reported low 49 detection yields in sputum-positive TB cases. To increase the utility of bioaerosol sampling, we present 50 advances in bioaerosol collection and Mtb identification that improve detection yields. Methods A previously described Respiratory Aerosol Sampling Chamber (RASC) protocol, or "RASC-1", was 52 modified to incorporate liquid collection of bioaerosol using a high-flow wet-walled cyclone (RASC-2). Individuals with GeneXpert-positive pulmonary TB were sampled pre-treatment over 60-minutes. Putative Mtb 54 bacilli were detected in collected fluid by fluorescence microscopy utilising DMN-Trehalose. Exhaled air and 55 bioaerosol volumes were estimated using continuous CO 2 monitoring and airborne particle counting, 56 respectively. Mtb capture was calculated per exhaled air volume sampled and bioaerosol volume for RASC-1 57 (n=35) and for RASC-2 (n=21). Empty chamber samples were collected between patients as controls. Tuberculosis (TB) remains a serious global public health threat [1]. In 2018, the global incidence was estimated 72 at 10 million with a death toll of 1.5 million [2] . Driving the high burden is on-going transmission of infection, 73 as demonstrated by the 1.1 million cases of childhood TB disease globally. Further evidence for the prominence 74 All rights reserved. No reuse allowed without permission. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. We describe a direct bioaerosol sampling device designed to collect aged aerosol. We have attempted to 103 optimise key components necessary to maximise detection yield through an iterative re-design process. Preliminary results of sampling from both healthy controls and individuals with newly diagnosed pulmonary TB 105 are also presented. Mounted within the chamber, the air enters the conical collector through a tangential nozzle. The high flow rate 127 of 250 L/min generates a liquid cyclone and particle inertia leads to deposition of bioaerosol from the airstream 128 onto the wet wall with a high collection efficiency. Collection into liquid has the advantage of minimizing 129 particle bounce, improving the recovery of viable Mtb bacilli and maximizing the air volume sampled over time. Sampling Protocol 131 All rights reserved. No reuse allowed without permission. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint (which this version posted May 8, 2020. volume of respiratory bioaerosol were calculated using the method described in the previous (RASC-1) study 155 [12] . All recruited participants were residents from two informal peri-urban settlements outside Cape Town and in 158 close proximity to the study site. Eligible candidates were those with GeneXpert-positive sputum without 159 evidence of drug resistance. Bioaerosol sampling was performed before initiation of anti-tuberculous therapy, as 160 per the approved Ethics protocol (see below). The empty chamber was sampled between human participants to 161 serve as chamber decontamination controls. Baseline patient data were collected from the clinical records and a 162 All rights reserved. No reuse allowed without permission. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint (which this version posted May 8, 2020. . https://doi.org/10.1101/2020.05.03.20089425 doi: medRxiv preprint chest X-ray was taken approximately seven days after the start of treatment. The presence of lung cavitation was 163 scored by one of the authors (BP) based on the chest X-ray and this score was compared to a radiologist report 164 for agreement. The two RASC designs were compared using indicators of sampling efficiency ( Fig. 2A and 2B ) and numbers 185 of Mtb bacilli captured (Fig. 2C) . The sampled volume of exhaled air was calculated using continuous CO 2 186 measurement to determine exhaled air proportion in chamber air during device sampling. Similarly, chamber 187 bioaerosol concentration was determined by particle counting and volume calculation with the assumption that 188 bioaerosol are spherical. Captured bioaerosol volume was estimated by assuming completely efficient sampling 189 of this concentration. Both these methods have been described previously [11] . 190 All rights reserved. No reuse allowed without permission. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint (which this version posted May 8, 2020. This study has shown that, by optimising both bioaerosol collection and Mtb detection, a majority of newly 214 diagnosed GeneXpert sputum positive TB patients can be shown to exhale viable Mtb organisms. The increased 215 numbers of Mtb organisms captured by RASC-2 compared with RASC-1 were associated with an approximate 1 216 log 10 increase in exhaled air sampled and bioaerosol particle volume collected. This is not explained by 217 demographic and clinical characteristics which were broadly equivalent between the patients sampled by the 218 different methods. The resulting lowered limit of detection enabled identification of putative Mtb organisms in 219 95% of patients whose bacillary concentrations varied over a 2 log 10 range from 1 to 100 per 100 L exhaled air. The proportion of patients identified with Mtb positive bioaerosols is therefore a function of lower level of 221 detection. However, exhaled particle volumes varied markedly between individuals, suggesting that infectivity 222 is likely to be impacted by both Mtb concentration of lung fluids and individual bioaerosol particle production. 223 All rights reserved. No reuse allowed without permission. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint (which this version posted May 8, 2020. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint (which this version posted May 8, 2020. . https://doi.org/10.1101/2020.05.03.20089425 doi: medRxiv preprint Geneva: World Health Organization Transmission of Tuberculosis in a South African Community With a High Prevalence of HIV Infection Aerial dissemination of pulmonary tuberculosis. A two-year study of contagion in a 257 tuberculosis ward Tuberculosis disseminators. A study of the variability of aerial infectivity of tuberculous 260 patients Droplets, dust and guinea pigs: an historical review of tuberculosis transmission research Seminal Mycobacterium Tuberculosis in vivo Transmission Studies Aerial dissemination of pulmonary 269 tuberculosis: A two-year study of contagion in a tuberculosis ward Natural infection of guinea pigs exposed to patients with highly drug-resistant tuberculosis The Infectiousness of 275 tuberculosis patients co-infected with HIV Detection of Mycobacterium tuberculosis bacilli in bio-aerosols from untreated TB patients No reuse allowed without permission. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint Cough-280 generated Aerosols ofMycobacterium tuberculosis Face Mask Sampling for the Detection of Mycobacterium tuberculosis in Expelled Aerosols Real-Time Investigation of Tuberculosis Transmission: Developing the Respiratory Aerosol Sampling Chamber 287 (RASC) Capture and visualization of live Mycobacterium 292 tuberculosis bacilli from tuberculosis bioaerosols Thoracic and respirable particle definitions for 295 human health risk assessment Nowcasting and forecasting the potential domestic and 298 international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. The Lancet All rights reserved. No reuse allowed without permission.was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint (which this version posted May 8, 2020. . https://doi.org/10.1101/2020.05.03.20089425 doi: medRxiv preprint